OGN

Organon & Co.

Halal Rating :
Uncomfortable
See Details
Last Price $17.56 Last updated:
Market Cap $4.56b
7D Change -5.08%
1 Year Change -27.17%

Company Overview

Industries
Exchange NYSE
Next Earnings Date Feb. 15, 2024

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $1.6b $2.23b - $129m 0.00% 5.78%
Sept. 30, 2023 $1.52b $1.96b - $134m 0.00% 6.84%
June 30, 2023 $1.61b $1.8b - $132m 0.00% 7.33%

Company Impact

Help us evaluate Organon & Co.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates